Almotriptan Malate
2 NDCs across 1 manufacturer|2 Generic,0 Brand
Almotriptan Malate is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 7, 2001, and the first generic was approved Jul 7, 2015. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Almotriptan Malate across 5,489 claims for 1,436 beneficiaries.
Almotriptan Malate is available as 2 NDCs from 1 manufacturer (2 generic, 0 brand), with NADAC prices from $16.51 to $16.86 per EA — a 2% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
1
competing in market
Price Spread
$16.51 – $16.86
per EA
7d Activity
avg -2.6% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ALMOTRIPTAN MALATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ALMOTRIPTAN MALATE 12.5 MG TAB | $16.8566 per EA | -2.25% |
ALMOTRIPTAN MALATE 6.25 MG TAB | $16.5091 per EA | -3.02% |
Frequently Asked Questions
What is Almotriptan Malate used to treat?
Almotriptan Malate is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.
When did Almotriptan Malate become available as a generic?
FDA approved the first generic Almotriptan Malate (ANDA) on Jul 7, 2015. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Almotriptan Malate?
In 2024, Medicare Part D spent $2 million on Almotriptan Malate across 5,489 claims for 1,436 beneficiaries.
How many Almotriptan Malate products are on the market?
The Almotriptan Malate drug market contains 2 NDCs from 1 manufacturer — 2 generic and 0 brand products.
What is the price range for Almotriptan Malate?
NADAC reference prices for Almotriptan Malate range from $16.5091 to $16.8566 per EA — a 2% difference between cheapest and most expensive.
Which manufacturers make Almotriptan Malate?
1 manufacturer lists Almotriptan Malate in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (2).
How has the price of Almotriptan Malate changed recently?
Over the past 7 days, 0 Almotriptan Malate NDCs rose and 2 fell, with a market-wide average change of -2.6%.